Epistatic interactions govern chemically-induced lung tumor susceptibility and Kras mutation site in murine C57BL/6J-ChrA/J chromosome substitution strains
- PMID: 19609923
- PMCID: PMC2783521
- DOI: 10.1002/ijc.24743
Epistatic interactions govern chemically-induced lung tumor susceptibility and Kras mutation site in murine C57BL/6J-ChrA/J chromosome substitution strains
Abstract
Cancer susceptibility results from interactions between sensitivity and resistance alleles. We employed murine chromosome substitution strains to study how resistance alleles affected sensitive alleles during chemically-induced lung carcinogenesis. The C57BL/6J-Chr#(A/J) strains, constructed by selectively breeding sensitive A/J and resistant C57BL/6J (B6) mice, each contain one pair of A/J chromosomes within an otherwise B6 genome. Pas1, the major locus responsible for this differential strain response to urethane carcinogenesis, resides on Chr 6, but C57BL/6J-Chr6(A/J) mice (hereafter CSS-6) developed few tumors following a single urethane injection, which demonstrates epistatic interactions with other B6 alleles. CSS6 mice developed dozens of lung tumors after chronic urethane exposure, however, indicating that these epistatic interactions could be overcome by repeated carcinogen administration. Unlike A/J, but similar to B6 mice, CSS6 mice were resistant to lung carcinogenesis induced by 3-methylcholanthrene (MCA). Tumor multiplicity increased if BHT administration followed urethane exposure, showing that a Chr 6 gene(s) regulates sensitivity to chemically-induced tumor promotion. Unlike A/J tumors (predominantly codon 61 A-->T transversions), Kras mutations in tumors induced by urethane in CSS-6 mice were similar to B6 tumors (codon 61 A-->G transitions). DNA repair genes not located on Chr 6 may determine the nature of Kras mutations. CSS-6 mice are a valuable resource for testing the ability of candidate genes to modulate lung carcinogenesis.
Figures
Similar articles
-
Analysis of lung tumorigenesis in chimeric mice indicates the Pulmonary adenoma resistance 2 (Par2) locus to operate in the tumor-initiation stage in a cell-autonomous manner: detection of polymorphisms in the Poli gene as a candidate for Par2.Oncogene. 2003 Apr 17;22(15):2374-82. doi: 10.1038/sj.onc.1206387. Oncogene. 2003. PMID: 12700672
-
Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations.Oncogene. 1997 Oct 9;15(15):1833-40. doi: 10.1038/sj.onc.1201357. Oncogene. 1997. PMID: 9362450
-
Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors.Oncogene. 2008 Sep 25;27(43):5753-8. doi: 10.1038/onc.2008.194. Epub 2008 Jun 16. Oncogene. 2008. PMID: 18560355
-
Differential sensitivity to lung tumorigenesis following transplacental exposure of mice to polycyclic hydrocarbons, heterocyclic amines, and lung tumor promoters.Exp Lung Res. 2000 Dec;26(8):709-30. doi: 10.1080/01902140150216774. Exp Lung Res. 2000. PMID: 11195466 Review.
-
Polygenic resistance to mouse pulmonary adenomas.Exp Lung Res. 2000 Dec;26(8):617-25. doi: 10.1080/01902140150216701. Exp Lung Res. 2000. PMID: 11195459 Review.
Cited by
-
Danger zone.Elife. 2021 May 17;10:e69192. doi: 10.7554/eLife.69192. Elife. 2021. PMID: 33998996 Free PMC article.
-
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas.J Clin Invest. 2023 Apr 3;133(7):e164413. doi: 10.1172/JCI164413. J Clin Invest. 2023. PMID: 36928090 Free PMC article.
-
Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice.Sci Rep. 2016 Jun 2;6:27295. doi: 10.1038/srep27295. Sci Rep. 2016. PMID: 27250582 Free PMC article.
-
Capturing the primordial Kras mutation initiating urethane carcinogenesis.Nat Commun. 2020 Apr 14;11(1):1800. doi: 10.1038/s41467-020-15660-8. Nat Commun. 2020. PMID: 32286309 Free PMC article.
-
Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development.Oncoscience. 2016 Nov 17;3(11-12):322-336. doi: 10.18632/oncoscience.323. eCollection 2016. Oncoscience. 2016. PMID: 28105457 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008 Mar;58(2):71–96. - PubMed
-
- Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers--a different disease. Nat Rev Cancer. 2007 Oct;7(10):778–90. - PubMed
-
- Bauer AK, Malkinson AM, Kleeberger SR. Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities. Am J Physiol Lung Cell Mol Physiol. 2004 Oct;287(4):L685–L703. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
